Konferenzen  >  Biowissenschaften  >  Biotechnologie  >  Vereinigte Staaten

ComplianceOnline

US FDA statements and actions indicate the initial and purpose of Part 11 "Add-on" inspections are being extended beyond what was to be a short term review of industry's response to Part 11. Using the field tested techniques presented in this webinar, an internal and/or supplier audit can provide much the same early warnings as a real FDA compliance CGMP audit. This webinar will provide test scripts and rationale for a "model" for company internal and supplier audits.

Event Manager;     Tel.: [+1-888-717-2436];     Email: sshastry@complianceonline.com

Audits for CGMP Compliance, Old QSR, New QMSR, Combo Products, Pharma and Dietary Supplements, Internal and Supplier Audits, Virtual Audits, Layered Process Audits, ISO 13485, ICH Q7, ISO 9001 GMP, QMS, CAPA Requirements, Root Cause Analysis Tools, Six Sigma, Problem Solving Tools, Methodology, FDA Requirements, Management Responsibility

CHI

OPT Congress is the premier conference for scientists and clinicians involved in discovering and developing oligonucleotides as therapeutics. For 2025 we are delighted to expand our content and offer a new conference program dedicated to emerging oligo modalities to showcase where the science is heading in the very near future and share cutting-edge research and technologies with community. Now in its 10th year, this unique event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotides and mRNA therapeutics. In addition to 2 days of inspiring keynotes, interactive discussions and more than 95 scientific presentations, we deliver in-depth short courses to further add to the learning opportunities while you are on site with us. We look forward to having you join us for this important scientific and networking event, that offers robust and customizable programming.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Oxford Global

Advancing therapeutic Innovation through Multi-Omic Analysis – Celebrating its 11th Year. Join us at NextGen Omics & Spatial Biology US 2025, a premier event celebrating its 11th year of advancing therapeutic innovation through multi-omic analysis. This gathering brings together over 1,000 senior experts in multi-omics and spatial analysis from leading pharmaceutical, biotech, and life sciences companies, creating a vibrant platform for collaboration and innovation.

Tel.: [01865 248 455];     Email: k.thande@oxfordglobal.com

Built with industry experts in-mind, the conference programme highlights: • Hear from and meet with key innovators in genomics • Discuss digital PCR & Liquid Biopsies. • Join a series of workshops, panel discussions and roundtables • Advance your understanding of emerging single cell technologies • Take a deep dive into data harmonisation, integration and analysis. Take a look here and discover the NextGen Omics & Spatial Biology US 2025 agenda.

EBD Group

Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market.

Tel.: [8018919874];     Email: christopher.chang@informa.com

partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, China, life science

Singularity University

In May 2025 in San Diego, we will host experts, innovators, and executives from diverse industries to explore and shape the future of biotech-driven innovation.

Singularity Programs Team;     Tel.: [1-650-200-3434];     Email: programs@su.org

AI, Bio-informed innovation, Wast-to-value, Micro-bio Workforce, Digital Biology, Bio-Mining, Bio-energy, Bio-Manufacturing, Future of Food

Systembiologie und mathematische Biologie,    Genomforschung und Bioinformatik

CHI

The 2025 PEGS Boston Summit is set to build on the remarkable success of previous years, continuing its legacy as the premier event for biologics and protein engineering. Bringing together a global community of experts, innovators, and leaders in the field, the Summit will offer cutting-edge insights into the latest advances in drug development, protein and antibody engineering, immunotherapy, radiotherapy, and AI/ML-driven biologics research. With over 300 presentations, breakout sessions, and interactive seminars, attendees will have unparalleled opportunities to network, learn, and engage in meaningful collaborations. The exhibit hall will once again feature top product and service providers, creating a gathering space for discovery, innovation, and fun. Join us at the PEGS Boston Summit to be part of the next wave of breakthroughs shaping the future of biologics.

Tel.: [781.972.5400];     Email: chi@healthtech.com